The Expression of Myeloid-Derived Suppressor Cells in an Orthotopic Transplantation Liver Tumor Model in Mice

ZHAO Wen-xiu,ZHANG Zheng-qi,XU Ya-ping,YIN Zhen-yu,WANG Xiao-min
DOI: https://doi.org/10.3760/cma.j.issn.1001-9030.2013.10.018
2013-01-01
Abstract:Objective To investigate the expression of myeloid-derived suppressor cells (MDSCs)in an orthotopic transplantation liver tumour model in BALB/c mice.Methods Ten healthy BALB/c mice were randomly divided into two groups (n =5 each):normal group and tumor-bearing group.The murine hepatic cancer cell line H22 cells were transplanted into the left liver lobe of mice to establish an orthotopic transplantation liver tumor model.The mice were sacrificed at 10th day.The expression of MDSCs in peripheral blood,bone marrow,spleen and liver was analyzed by flow cytometry.Results The presence of CD11b+ Gr-1 + MDSCs was significantly increased in the peripheral blood,bone marrow,and spleen of tumor-bearing mice [(47.73 ±.6.00),(71.90 ±4.30),(11.21 ± 1.19)%] as compared with normal mice [(18.33 ±2.31),(59.03 ±4.50),(5.82 ±0.58)%].The percentage of CD11b+ Gr-1 + MDSCs of intrahepatic leukocytes in normal mice was 6.5%.However,the percentage of MDSCs of intrahepatic leukocytes in tumor and paracancerous tissue was up to 43.8% and 12.8% respectively.Conclusion MDSCs were elevated in an orthotopic transplantation tumor mouse model of hepatocellular carcinoma.The mouse model can serve to study the role of MDSCs in hepatocellular carcinoma development.
What problem does this paper attempt to address?